期刊文献+

乙酰化修饰抑制α-synuclein的纤维化聚集(英文) 被引量:2

Lysine Acetylation Inhibits α-Synuclein Fibrillation
下载PDF
导出
摘要 天然无结构蛋白α-synuclein(α-syn)的纤维化聚集是帕金森病的特征表现.静电相互作用已被证明会显著影响α-syn的聚集.该文通过简单的赖氨酸乙酰化修饰改变蛋白的净电荷,研究静电效应对于α-syn的构象和纤维化聚集的影响.核磁共振(NMR)实验结果表明乙酰化后的α-syn仍然是无序结构,而且展现出比野生型更加伸展的构象.由于N端和C端都高度带负电荷,结构打开会更加暴露NAC区域,静电排斥和疏水作用共同存在,但Th T荧光实验发现乙酰化修饰抑制了它的纤维化聚集,因此我们认为这里静电排斥占据主导作用.这种依赖电荷的作用机理会帮助我们更好地理解α-syn的纤维化聚集,而乙酰化修饰也提供了一种抑制聚集的新方法. Fibrils of intrinsically disordered protein α-synuclein(α-syn) are hallmarks of Parkinson's disease. Electrostatic interactions are known to contribute significantly on α-syn aggregation. Here we studied how α-syn conformation and fibrillation were affected by changing the net charge of the protein via acetylation of lysine side chains. NMR spectroscopy results showed that lysine-acetylated α-syn remained disordered, and showed a more extended conformation, relative to wild-type protein. Acetylation inhibited α-syn fibrillation, revealed by thioflavin(Th T) fluorescence assay. The N- and C-terminals of the acetylated protein were highly negative charged, causing increased exposure of the non-amyloid-b component(NAC) region. It is proposed that, with the charge distribution in the acetylated protein, electrostatic repulsion, instead of hydrophobic effect, may contribute predominately to the aggregation. This charge-effect mechanism may constitute a new strategy to inhibit α-syn fibrillation.
出处 《波谱学杂志》 CAS CSCD 北大核心 2016年第2期179-187,共9页 Chinese Journal of Magnetic Resonance
基金 Ministry of Science and Technology of China(2013CB910200) National Natural Science Foundation of China(21173258,21120102038 and 21221064)
关键词 液体核磁共振(liquid-state NMR) 乙酰化修饰 纤维化聚集 Α-SYNUCLEIN liquid-state NMR acetylation fibrillation α-synuclein
  • 相关文献

参考文献22

  • 1Goedert M. Alpha-synuclein and neurodegenerative diseases[J]. Nat Rev Neurosci, 2001, 2(7): 492- 501.
  • 2Trojanowski J Q, Lee V M Y. Parkinson's disease and related alpba-synucleinopatbies are brain amyloidoses[J]. Ann NY Aead Sci, 2003, 991: 107- 110.
  • 3Spillantini M G, Crowther R A, Jakes R, et al. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies[J]. Proc Natl Acad Sci U S A, 1998, 95(11): 6 469-6 473.
  • 4Ulmer T S, Bax A, Cole N B, et al. Structure and dynamics of micelle-bound human alpba-synuclein[J]. J Biol Chem, 2005, 280(10): 9 595-9 603.
  • 5Bussell R J, Eliezer D. A structural and functional role for ll-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins[J]. J Mol Biol, 2003, 329(4): 763- 778.
  • 6E1-Agnaf O M A, Bodles A M, Guthrie D J S, et al. The N-terminal region of non-A beta component of Alzheimer's Disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils[J]. Eur J Biochem, 1998, 258(1): 157-163.
  • 7Murray I V J, Giasson B I, Quinn S M, et al. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro[J]. Biochemistry, 2003, 42(28): 8 530-8 540.
  • 8Uversky V N. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation[J], J Neurochem, 2007, 103(1): 17-37.
  • 9Wood S J, Wypych J, Steavenson S, et al. Alpha-synuclein fibrillogenesis is nucleation-dependent: Implications for the pathogenesis of Parkinson's disease[J]. J Biol Chem, 1999, 274(28): 19 509-19 512.
  • 10Uversky V N, Li J, Fink A L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation[J]. J Biol Chem, 2001, 276:10 737-10 744.

同被引文献4

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部